Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-06-26

Clinical Trial Update: Sarcosine or D-Serine Add-on Treatment for Chronic Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating add-on sarcosine or D-serine for chronic schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • D-serine (D-serine)
  • Sarcosine (sarcosine)

Snippet

Sponsor: China Medical University Hospital | Conditions: Schizophrenias, Psychoses | Phase 2 | Status: COMPLETED